173 related articles for article (PubMed ID: 27341638)
1. Spatiotemporal Co-existence of Female Thyroid and Breast Cancers in Hangzhou, China.
Fei X; Christakos G; Lou Z; Ren Y; Liu Q; Wu J
Sci Rep; 2016 Jun; 6():28524. PubMed ID: 27341638
[TBL] [Abstract][Full Text] [Related]
2. Contribution of industrial density and socioeconomic status to the spatial distribution of thyroid cancer risk in Hangzhou, China.
Fei X; Lou Z; Christakos G; Liu Q; Ren Y; Wu J
Sci Total Environ; 2018 Feb; 613-614():679-686. PubMed ID: 28938210
[TBL] [Abstract][Full Text] [Related]
3. Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancer.
Huang NS; Chen XX; Wei WJ; Mo M; Chen JY; Ma B; Yang SW; Xu WB; Wu J; Ji QH; Guo XM; Liu GY; Shao ZM; Wang Y
Cancer Med; 2018 Dec; 7(12):6393-6400. PubMed ID: 30480382
[TBL] [Abstract][Full Text] [Related]
4. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
Piek MW; de Boer JP; van Duijnhoven F; van der Wal JE; Vriens M; van Leeuwaarde RS; van der Ploeg IMC
BMC Cancer; 2022 Sep; 22(1):1018. PubMed ID: 36163009
[TBL] [Abstract][Full Text] [Related]
5. Improving Spatiotemporal Breast Cancer Assessment and Prediction in Hangzhou City, China.
Lou Z; Fei X; Christakos G; Yan J; Wu J
Sci Rep; 2017 Jun; 7(1):3188. PubMed ID: 28600508
[TBL] [Abstract][Full Text] [Related]
6. A Possible Association Between Thyroid Cancer and Breast Cancer.
An JH; Hwangbo Y; Ahn HY; Keam B; Lee KE; Han W; Park DJ; Park IA; Noh DY; Youn YK; Cho BY; Im SA; Park YJ
Thyroid; 2015 Dec; 25(12):1330-8. PubMed ID: 26442580
[TBL] [Abstract][Full Text] [Related]
7. A Geographic Analysis about the Spatiotemporal Pattern of Breast Cancer in Hangzhou from 2008 to 2012.
Fei X; Lou Z; Christakos G; Liu Q; Ren Y; Wu J
PLoS One; 2016; 11(1):e0147866. PubMed ID: 26808895
[TBL] [Abstract][Full Text] [Related]
8. The clinical and genetic features in patients coexisting primary breast and thyroid cancers.
Fu J; He M; Wu Q; Zhang X; Qi X; Shen K; Wang X; Zhang G
Front Endocrinol (Lausanne); 2023; 14():1136120. PubMed ID: 37229458
[TBL] [Abstract][Full Text] [Related]
9. The spatio-temporal distribution and risk factors of thyroid cancer during rapid urbanization-A case study in China.
Fei X; Chen W; Zhang S; Liu Q; Zhang Z; Pei Q
Sci Total Environ; 2018 Jul; 630():1436-1445. PubMed ID: 29554762
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.
Zhang L; Wu Y; Liu F; Fu L; Tong Z
Oncotarget; 2016 Aug; 7(32):52450-52459. PubMed ID: 27223440
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
[TBL] [Abstract][Full Text] [Related]
12. Increased prevalence of breast cancer among patients with thyroid and parathyroid disease.
Garner CN; Ganetzky R; Brainard J; Hammel JP; Berber E; Siperstein AE; Milas M
Surgery; 2007 Dec; 142(6):806-13; discussion 813.e1-3. PubMed ID: 18063060
[TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal Analysis of Breast Cancer Incidence: A Study in Southern Portugal Between 2005 and 2012.
Gomes I; Miranda A; Nunes C
Anticancer Res; 2018 Mar; 38(3):1797-1805. PubMed ID: 29491119
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
Lei K; He X; Yu L; Ni C; Chen H; Guan D; Sun K; Zou H
PLoS One; 2019; 14(5):e0215948. PubMed ID: 31042767
[TBL] [Abstract][Full Text] [Related]
15. Possible association between breast thyroid carcinoma: analysis of risk factors.
Del Rio P; Viani L; Bonati E; Marina M; Arcuri MF; Ceresini G
Ann Ital Chir; 2020; 91():173-180. PubMed ID: 32719185
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and prognostic analysis of double primary breast cancer and thyroid cancer].
Zhai J; Kong XY; Fang Y; Wang J
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1287-1291. PubMed ID: 34915638
[No Abstract] [Full Text] [Related]
17. Second primary breast and thyroid cancers (Israel).
Sadetzki S; Calderon-Margalit R; Peretz C; Novikov I; Barchana M; Papa MZ
Cancer Causes Control; 2003 May; 14(4):367-75. PubMed ID: 12846369
[TBL] [Abstract][Full Text] [Related]
18. Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
Cheng W; Shen X; Xing M
PLoS One; 2019; 14(10):e0221093. PubMed ID: 31644578
[TBL] [Abstract][Full Text] [Related]
19. Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation.
Baumgarten MW; Goemann IM; Scheffel RS; Maia AL
Clin Breast Cancer; 2024 Apr; ():. PubMed ID: 38670860
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies.
Song QK; Wang XL; Zhou XN; Yang HB; Li YC; Wu JP; Ren J; Lyerly HK
Oncologist; 2015 Jul; 20(7):773-9. PubMed ID: 26001390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
